Literature DB >> 23133156

Systemic inflammatory response syndrome outcome in surgical patients.

Simrandeep Singh1, Pradeep Singh, Gurjit Singh.   

Abstract

INTRODUCTION: The problems of inflammation and infection as a leading cause of organ dysfunction and failure is a major problem after injury or operations. When systemic inflammatory response syndrome (SIRS) progress to multiple organ failure (MOF), the mortality reach up to 30-80% depending on the number of failed organs. Recent discoveries and improvement in patient care, a reasonable question then arises, are the incidence of MOF decreasing? The literature suggests a decrease in mortality of patients with severe organ failure and a decrease in elective surgical mortality in patients.
METHODS: This is prospective study of 50 patients who underwent surgical procedure. They were followed up till date of termination with daily SIRS monitoring, development of MODS and MOF. Risk factors for MOF are addressed.
RESULTS: There are total 31 patients who develop SIRS, of whom 7 patients develop severe sepsis and 4 went into MOF.
CONCLUSION: Early detection of SIRS helps us to prevent multiple organ dysfunction syndrome (MODS)/MOF, leading to lesser hospital stay and better outcome.

Entities:  

Keywords:  MODS; MOF; SIRS

Year:  2009        PMID: 23133156      PMCID: PMC3452625          DOI: 10.1007/s12262-009-0062-z

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  14 in total

Review 1.  Sex steroids/receptor antagonist: their use as adjuncts after trauma-hemorrhage for improving immune/cardiovascular responses and for decreasing mortality from subsequent sepsis.

Authors:  Raghavan Raju; Irshad H Chaudry
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

2.  Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation.

Authors:  M Talmor; L Hydo; P S Barie
Journal:  Arch Surg       Date:  1999-01

3.  The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection.

Authors:  Nathan Shapiro; Michael D Howell; David W Bates; Derek C Angus; Long Ngo; Daniel Talmor
Journal:  Ann Emerg Med       Date:  2006-11       Impact factor: 5.721

Review 4.  Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation.

Authors:  R C Bone
Journal:  Crit Care Med       Date:  1996-01       Impact factor: 7.598

Review 5.  Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle?

Authors:  A E Baue; R Durham; E Faist
Journal:  Shock       Date:  1998-08       Impact factor: 3.454

6.  The influence of sepsis and multisystem and organ failure on mortality in the surgical intensive care unit.

Authors:  L Manship; R D McMillin; J J Brown
Journal:  Am Surg       Date:  1984-02       Impact factor: 0.688

7.  Multiple organ failure in polytrauma patients.

Authors:  E Faist; A E Baue; H Dittmer; G Heberer
Journal:  J Trauma       Date:  1983-09

Review 8.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; Mitchell M Levy
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

9.  Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients.

Authors:  D Pittet; S Rangel-Frausto; N Li; D Tarara; M Costigan; L Rempe; P Jebson; R P Wenzel
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

10.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.

Authors:  M S Rangel-Frausto; D Pittet; M Costigan; T Hwang; C S Davis; R P Wenzel
Journal:  JAMA       Date:  1995-01-11       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.